Motion and IntraCoronary Ecg Ischemia Development Study (MICE)
MICE
1 other identifier
observational
30
1 country
1
Brief Summary
The concept of the "ischemic cascade" is generally accepted hypothesis, according to which whenever ischemia of the myocardium occurs there is a consequence of events, that always occur in a given order - diastolic dysfunction first, followed by systolic dysfunction, then changes on electrocardiogram (ECG) and finally chest pain sensation. The occurrence of every next stage of cascade means more severe ischemia and respectively - more severe myocardial damage. We propose that mechanical and electrical changes in the myocardium during ischemia appear simultaneously.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2019
CompletedFirst Submitted
Initial submission to the registry
August 15, 2019
CompletedFirst Posted
Study publicly available on registry
August 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedAugust 19, 2019
August 1, 2019
2.9 years
August 15, 2019
August 16, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Side branch region ischemia
Beginning, duration, sequence of the electric, kinetic and haemodynamic signs of ischemia, comparison between ischemic cascade and constellation.
Percutaneous coronary intervention procedure time (up to 4 hours)
Secondary Outcomes (4)
Target lesion revascularization
12 months
Number of patients not alive
12 months
Myocardial infarction after hospital discharge
12 months
New onset angina or heart failure symptoms
12 months
Other Outcomes (1)
Periprocedural myonecrosis - extent of post PCI enzyme elevation
48 hours
Study Arms (1)
Patients with coronary bifurcation lesions
Patients from 18 to 90-years old with coronary bifurcation lesions with significant \>50% diameter stenosis artery scheduled for intervention of the main vessel (Medina types: 1x1, x11, 111)
Interventions
Measurement of fractional flow reserve (FFR), registration of intracoronary ECG and radioscopic registration of wire tip movement in the main and in the side branch in the beginning, at the end and during every step of coronary bifurcation percutaneous intervention.
Eligibility Criteria
* Significant, \>50% diameter stenosis artery scheduled for intervention of the main vessel (Medina types: 1x1, x11, 111); * Side branch vessel at least 2.0 mm
You may qualify if:
- Subject at least 18 years of age.
- Subject able to verbally confirm understandings of risks, benefits of receiving PCI for true bifurcation lesions, and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
- Target main branch lesion(s) located in a native coronary artery with diameter of ≥ 2.5 mm and ≤ 4.5 mm. Target side branch lesion(s) located in a native coronary artery with diameter of ≥ 2.0 mm.
- Target lesion(s) amenable for PCI with balloon angioplasty of the side branch.
You may not qualify if:
- Subjects with significant ST-T change (≥ 1mm).
- Non-cardiac co-morbid conditions are present with life expectancy \<1 year or that may result in protocol non-compliance (per site investigator's medical judgment).
- Subjects who refuse to give informed consent.
- Subjects with the following angiographic characteristics: left main coronary artery stenosis, total occlusion before occurrence of SB, lesion of interest located at infarct-related artery.
- Subjects with LVEF \< 30%.
- Subjects with moderate or severe degree valvular heart disease or primary cardiomyopathy.
- LBBB, RBBB, atrial fibrillation/flutter with no identifiable isoelectric line.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Alexandrovska University Hospital
Sofia, Bulgaria
Related Publications (1)
Vassilev DI, Mileva NB, Yaneva-Sirakova T, Georgiev RS, Kassab G. Validation of Coronary Wire for the Acquisition of Intracoronary Electrocardiogram in Swine. Catheter Cardiovasc Interv. 2025 Nov;106(5):3030-3033. doi: 10.1002/ccd.70145. Epub 2025 Sep 7.
PMID: 40916341DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dobrin Vassilev
Principal Investigator
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 15, 2019
First Posted
August 19, 2019
Study Start
February 1, 2019
Primary Completion
January 1, 2022
Study Completion
January 1, 2024
Last Updated
August 19, 2019
Record last verified: 2019-08